Related Experiment Video
Updated: Aug 7, 2026

Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation
Published on: February 29, 2020
Choanal atresia associated with prenatal methimazole exposure: three new patients
P Barbero1, C Ricagni, G Mercado
1Centro Nacional de Genética Médica, Buenos Aires, Argentina. pablo@genes.gov.ar
Abstract:
We report three patients with bilateral choanal atresia in children prenatally exposed to methimazole (MMI) in order to define a MMI embryopathy clinical pattern. The combination of choanal atresia and other specific malformations strongly resembles previously reported patients exposed to MMI in utero. At present, propylthiouracil is considered the best treatment in pregnancies. However in Argentina and some other countries MMI is the only antithyroid drug, possibly posing a significant risk to the unborn fetus.
Insights
Prenatal exposure to methimazole (MMI) may cause a distinct pattern of birth defects, including choanal atresia. This highlights potential risks of MMI during pregnancy, especially where it
Area of Science:
- Pediatric Endocrinology
- Teratology
- Developmental Biology
Background:
- Methimazole (MMI) is an antithyroid drug used during pregnancy.
- Concerns exist regarding potential teratogenic effects of MMI.
- Bilateral choanal atresia is a congenital condition affecting newborns.
Purpose of the Study:
- To define a clinical pattern of methimazole embryopathy.
- To investigate the association between prenatal MMI exposure and choanal atresia.
- To assess the risks of MMI in pregnant populations.
Main Methods:
- Case report of three pediatric patients.
- Clinical examination and assessment of prenatal exposure history.
- Comparison with existing literature on MMI embryopathy.
Main Results:
- Three patients presented with bilateral choanal atresia and other malformations.
- The observed pattern aligns with previously documented MMI embryopathy.
- Methimazole exposure in utero is implicated in these congenital anomalies.
Conclusions:
- A distinct MMI embryopathy pattern, including choanal atresia, is suggested.
- Propylthiouracil is preferred over MMI in pregnancy where available.
- MMI use in certain regions poses a significant risk to fetal development.

